cms_AK: 68
Data source: Big Local News · About: big-local-datasette
rowid | facility_name | facility_id | address | city | state | zip | inspection_date | deficiency_tag | scope_severity | complaint | standard | eventid | inspection_text | filedate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
68 | WRANGELL MEDICAL CENTER LTC | 25015 | P.O. BOX 1081 | WRANGELL | AK | 99929 | 2018-04-30 | 757 | D | 0 | 1 | O8F911 | **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview the facility failed to ensure 1 resident's (#10), out of 8 sampled residents, drug regimen was free from unnecessary drugs. The failed practice exposed the resident to 2 drugs without adequate indications for their use or continued use. As a result, this placed the resident at risk for adverse reactions and tolerance to drug therapy. Findings: Record review on 4/23-27/18, revealed Resident #10 was admitted to facility with [DIAGNOSES REDACTED]. Medication: [MEDICATION NAME] Review of Resident #10's medical record revealed physician's orders [REDACTED]. Record review of physician notes, dated 10/7/17 to 1/5/18, revealed multiple notes indicating treatment with [MEDICATION NAME] ineffective: -10/7/17 - .continues (to) complain of (body) pain even though we started (Resident #10) on [MEDICATION NAME] to treat what seemed like active [MEDICATION NAME]. -10/31/17 - .continuing to complain of (pain) which is related to .shingles and is now being treated with [MEDICATION NAME]. -12/5/17 - .continues to have chronic pain related to the open shingles [MEDICAL CONDITION] . -12/19/17 - chronic shingles .with suboptimal response to [MEDICATION NAME] .complains of chronic pain .as well as pain over (Resident #10's) [MEDICAL CONDITION] for which we have not made much progress .increase (Resident's) dose of [MEDICATION NAME] to 1000mg (twice a day) . -1/5/18 - Patient still complaining of 10 out of 10 pain .today I cultured the open wound on (the Resident) .if this does not grow any [MEDICAL CONDITION] I will discontinue oral [MEDICAL CONDITION] medication . Review of Resident #10's lab work, since admission, revealed the Physician ordered a [MEDICAL CONDITION] culture on 1/5/18 which had negative results for [MEDICAL CONDITION] Simplex Virus (HSV). Further review of the resident's medical record revealed [REDACTED]. Review of Resident #10's monthly Drug Regimen Reveiws revealed no review in (MONTH) (YEAR). During an interview on 4/27/18 at 11:05 am, the Pharmacist agreed the consultant pharmacist failed to confirm the necessity of the [MEDICAL CONDITION] mediation and communicate with the physician the lack of [MEDICAL CONDITION] testing. In addition, the Pharmacist stated the continued use of [MEDICATION NAME] with no results should have been noted on the monthly DRR. Medication: [MEDICATION NAME] Review of Resident #10's medical records revealed admission orders [REDACTED]. [MEDICATION NAME] was started on 10/2/17 for 7 days after lab work indicated a urinary tract infection [MEDICAL CONDITION]. [MEDICATION NAME] was restarted for 7 days on 10/31/17, rationale UTI. Review of Resident #10's physician notes and nursing notes from 10/24/17 to 10/31/18 did not reveal symptoms of UTI. Additional review revealed no further diagnostic testing. Review of Resident #10's physician note, dated 10/31/17, revealed Functional incontinence with chronic Foley as well as recurrent colonization versus UTI again showing colonization or UTI and will treat with [MEDICATION NAME] 500mg twice a day x 7 days. During an interview on 4/27/18 at 11:00 am, Lab Director confirmed only 1 UA, dated 10/2/17, and 1 culture and sensitivity, dated 10/3/17, was performed. During an interview on 4/27/18 at 11:05 am, the Pharmacist stated that if a Resident is colonized and there are no symptoms, the Resident should not have been treated with antibiotics on 10/31/17. The Pharmacist further stated validation of a proper indication for use of an antibiotic should always be conducted to prevent unnecessary use resulting in potential resistance. | 2020-09-01 |